Disease activity and left ventricular structure in patients with rheumatoid arthritis

Rheumatology (United Kingdom)

Volumn 54, Issue 3, 2015, Pages 511-519

  Midtbo, Helga ^a,b   Gerdts, Eva ^b   Kvien, Tore K ^c   Olsen, Inge C ^c   Hirth, Asle ^a   Davidsen, Einar Skulstad ^a   Semb, Anne Grete ^c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Cardiovascular disease; Disease activity; Hypertension; Rheumatoid arthritis

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL DISEASE ACTIVITY INDEX; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; SYSTOLIC BLOOD PRESSURE; WALL STRESS;

EID: 84941636030     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu368     Document Type: Article

References (38)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. Gerdts E, Cramariuc D, de Simone G et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008;9:809-15.
3. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52.
4. Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995;25:871-8.
5. Izzo R, de Simone G, Trimarco V et al. Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J 2013;34:3419-26.
6. Myasoedova E, Davis JM III, Crowson CS et al. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a populationbased cross-sectional study. Arthritis Rheum 2013;65: 1713-8.
7. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524-9.
8. Lindhardsen J, AhlehoffO, Gislason GH et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis 2011;70:929-34.
9. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
10. Norton S, Koduri G, Nikiphorou E et al. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology 2013;52:99-110.
11. Corrales A, Parra JA, Gonzalez-Juanatey C et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2013; 72:1764-70.
12. Arts EE, Fransen J, den Broeder AA, Popa CD, van Riel PL. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. Ann Rheum Dis 2014, Jan 23. doi: 10.1136/annrheumdis-2013-204531. [Epub ahead of print].
13. Provan SA, Semb AG, Hisdal J et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis 2011;70:812-7.
14. Semb AG, Rollefstad S, Provan SA et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 2013;40:359-68.
15. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
16. Smedstad LM, Vaglum P, Kvien TK, Moum T. The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis. J Rheumatol 1995;22:514-20.
17. Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 1998;25: 1078-84.
18. Davidsen ES, Liseth K, Omvik P, Hervig T, Gerdts E. Reduced exercise capacity in genetic haemochromatosis. Eur J Cardiovasc Prev Rehabil 2007;14:470-5.
19. Hirth A, Edwards NC, Greve G et al. Left ventricular function in children and adults after renal transplantation in childhood. Pediatr Nephrol 2012;27:1565-74.
20. Klarenbeek NB, Koevoets R, van der Heijde DM et al. Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis. Ann Rheum Dis 2011; 70:1815-21.
21. Felson DT, Smolen JS, Wells G et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573-86.
22. Lang RM, Bierig M, Devereux RB et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7: 79-108.
23. Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
24. de Simone G, Izzo R, Chinali M et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension 2010;56:99-104.
25. de Simone G, Devereux RB, Roman MJ et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994;23:1444-51.
26. Gaasch WH, Battle WE, Oboler AA, Banas JS Jr, Levine HJ. Left ventricular stress and compliance in man with special reference to normalized ventricular function curves. Circulation 1972;45:746-62.
27. Nagueh SF, Appleton CP, Gillebert TC et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
28. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press 2013;22:193-278.
29. Lavie CJ, Milani RV, Ventura HO et al. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007;100:1460-4.
30. Muiesan ML, Salvetti M, Monteduro C et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004;43:731-8.
31. Rudominer RL, Roman MJ, Devereux RB et al. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 2009;60: 22-9.
32. Takatsu M, Hattori T, Murase T et al. Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats. J Hypertens 2012;30:1845-55.
33. Masiha S, Sundstrom J, Lind L. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens 2013;27:13-7.
34. Zoccali C, Benedetto FA, Mallamaci F et al. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest 2003;33:561-6.
35. Daien CI, Fesler P, du Cailar G et al. Etanercept normalises left ventricular mass in patients with rheumatoid arthritis. Ann Rheum Dis 2013;72:881-7.
36. Kotyla PJ, Owczarek A, Rakoczy J et al. Infliximab treatment increases left ventricular ejection fraction in patients with rheumatoid arthritis: assessment of heart function by echocardiography, endothelin 1, interleukin 6, and NT-pro brain natriuretic peptide. J Rheumatol 2012;39:701-6.
37. Giles JT, Malayeri AA, Fernandes V et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum 2010;62:940-51.
38. Galderisi M, Henein MY, D'hooge J et al. Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes. Eur J Echocardiogr 2011;12:339-53.